Friday, May 6, 2016

TearLab Q1 revenue climbs 25%

TearLab Q1 revenue climbs 25%

May 4, 2016 by · Leave a Comment 

Tweet First quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 25% to $6.8-million from $5.4-million a year ago. A net total of 257 TearLab Osmolarity Systems were added in the first quarter of 2016, of which 167 were under the company’s new Flex program and 61 were purchased outside of the U.S. “While we had to […]

TearLab forecasts 25% jump in Q1 revenue

TearLab forecasts 25% jump in Q1 revenue

April 20, 2016 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) estimates revenue for the first quarter this year will be about $6.8-million, reflecting a 25% increase from the first quarter of 2015. In addition, TearLab estimates that a net total of 257 TearLab Osmolarity Systems were added in the first quarter of 2016, of which 167 were under the company’s new […]

TearLab Q4 revenue climbs 28%

TearLab Q4 revenue climbs 28%

March 8, 2016 by · Leave a Comment 

Tweet Fourth quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) was $6.8-million, up 28% from $5.3-million a year ago. For all of 2015, revenue rose 28% to $25.2-million from $19.7-million for 2014. A net total of 258 TearLab Osmolality Systems were added in the fourth quarter of 2015, of which 200 were under the company’s new Flex […]

TearLab estimates Q4 revenue rose 28%

TearLab estimates Q4 revenue rose 28%

February 1, 2016 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) expects to report revenue of approximately $6.8-million for the fourth quarter of 2015, up about 28% from the same quarter in 2014. In addition, TearLab estimated that a net total of 258 TearLab Osmolality Systems were added in the fourth quarter of 2015, of which 200 were under the company’s new […]

TearLab Q3 revenue climbs 27%

TearLab Q3 revenue climbs 27%

November 5, 2015 by · Leave a Comment 

Tweet Third quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 27% to $6.6-million from $5.2-million a year ago. A net total of 228 TearLab systems were added in the third quarter. “We delivered a strong growth quarter both sequentially and compared with the prior year by expanding our device base and continuing to establish the clinical […]

Medicare LCD confirms necessity of osmolarity testing in DED

Medicare LCD confirms necessity of osmolarity testing in DED

October 9, 2015 by · Leave a Comment 

Tweet First Coast Service Options, the Medicare area contractor for Florida, Puerto Rico and the U.S. Virgin Islands, has published a Local Coverage Determination (LCD) that confirms the role of tear osmolarity testing in the diagnosis and management of moderate-to-severe dry eye patients, according to TearLab (NASDAQ:TEAR; TSX:TLB). The First Coast LCD was recently published […]

Roth ups TearLab price target to $4

Roth ups TearLab price target to $4

August 7, 2015 by · Leave a Comment 

Tweet Roth Capital Partners has raised its price target for TearLab (NASDAQ:TEAR; TSX:TLB) to $4 from $3 after the company posted a 27% jump in second quarter revenue. The stock closed at $2.48 on Friday. “TearLab delivered one of its stronger quarters in some time as 2Q revenues notably beat our projection driven by an […]

TearLab Q2 revenue climbs 27%

TearLab Q2 revenue climbs 27%

August 7, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported net revenue of $6.3-million for the second quarter this year, up 27%, from $5-million a year ago. A total of 394 orders for TearLab systems were booked in the second quarter, of which 303 were under the company’s new Flex program and 28 were purchased outside of the U.S. […]

Doctors discuss importance of tear film osmolarity

Doctors discuss importance of tear film osmolarity

August 4, 2015 by · Leave a Comment 

Tweet In an Eyetube.net video segment of the CRST Journal Club (Cataract & Refractive Surgery Today), Dr. John Davidson, of Miramar Eye Specialists in Ventura County, CA, and Dr. Jay Pepose, of the Pepose Vision Institute in St. Louis, discuss the importance of optimizing the ocular surface prior to premium intraocular lens surgery. Dr. Pepose […]

TearLab names Wes Brazell as CFO

TearLab names Wes Brazell as CFO

July 6, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Wes Brazell as CFO, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage the company’s relationships and interactions with the investment community. He  succeeds William Dumencu, who will continue to support the company in a consulting role until the end […]

Next Page »

Email Newsletters with Constant Contact
Google+